HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.16
+0.21 (1.54%)
At close: Oct 16, 2026, 4:00 PM EDT
14.30
+0.15 (1.02%)
After-hours: Oct 16, 2026, 7:31 PM EDT
HUTCHMED (China) Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, HUTCHMED (China) stock has a consensus rating of "Strong Buy" and an average price target of $20.59. The average 1-year stock price forecast is 45.46% higher than the current stock price, while the lowest is $13.6 (-3.92%) and the highest is $33.27 (+135.04%).
Price Target: $20.59 (+45.46%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HUTCHMED (China) stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 7 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 3 | 3 | 3 | 4 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $16 → $18 | Buy | Reiterates | $16 → $18 | +27.16% | Sep 21, 2026 |
| Daiwa No rating | Daiwa | Buy Upgrades $19 | Buy | Upgrades | $19 | +30.70% | Sep 3, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $16 → $14 | Hold | Reiterates | $16 → $14 | -1.10% | Jul 23, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Upgrades $14 → $14 | Hold | Upgrades | $14 → $14 | -3.92% | May 28, 2026 |
Financial Forecast
Revenue This Year
626.61M
from 548.51M
Increased by 14.24%
Revenue Next Year
698.80M
from 626.61M
Increased by 11.52%
EPS This Year
0.06
from 0.52
Decreased by -88.31%
EPS Next Year
0.07
from 0.06
Increased by 14.39%
EPS and Forward PE are based on non-GAAP adjusted numbers.